Volume 36, Issue 10, Page 31 (October 2008)
42 of 61
PREVIEW
FULL TEXT
FULL-TEXT PDF (197 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
MEXICO CITY — Efavirenz twice daily is at least as effective as once-daily lopinavir/ritonavir, and likely more so, when it used as part of highly active antiretroviral therapy for untreated advanced HIV infection.
PII: S0270-6644(08)70719-7
doi:10.1016/S0270-6644(08)70719-7
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.